FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original generic application for raloxifene hydrochloride, enabling a generic version of the osteoporosis and breast cancer ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

ORIG AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE)